apixaban
SpainDrugs containing this active substance
-
It is used in adults to prevent blood clots after hip or knee surgery, to prevent clots in the heart in people with an irregular heartbeat (atrial fibrillation), and to treat blood clots in the veins of the legs or lungs. In children and adolescents, it is used to treat and prevent blood clots in the veins and blood vessels of the lungs.
Form: tablets, film-coated
Active substance Dosage apixaban 2,5 mg Manufacturer: Bristol-Myers Squibb/Pfizer Eeig
-
It is used in adults to prevent the formation of blood clots following hip or knee surgery, to prevent clots in the heart in people with an irregular heartbeat (atrial fibrillation), and to treat clots in the leg veins or lungs. In children and adolescents, it is used to treat and prevent clots in the veins and blood vessels of the lungs.
Form: tablets, film-coated
Active substance Dosage apixaban 2,5 mg Manufacturer: Bristol-Myers Squibb/Pfizer Eeig
-
It is used to prevent the formation of blood clots after hip or knee surgery, to prevent clots in the heart in people with irregular heartbeats, and to treat clots in the leg veins or lungs. It is also used in children to treat and prevent these clots in the lungs.
Form: tablets, film-coated
Active substance Dosage apixaban 2,5 mg Manufacturer: Bristol-Myers Squibb/Pfizer Eeig
-
It is used in adults to prevent blood clots in the heart in people with irregular heartbeat (atrial fibrillation), and to treat or prevent blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism). It is also used in children from 28 days to less than 18 years of age to treat and prevent blood clots in the lungs.
Form: tablets, film-coated
Active substance Dosage apixaban 5 mg Manufacturer: Bristol-Myers Squibb/Pfizer Eeig
-
It is used in adults to prevent the formation of blood clots in the heart in people with an irregular heartbeat (atrial fibrillation) and to treat or prevent blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism). It is also used in children from 28 days old up to less than 18 years of age to treat and prevent clots in the lungs and veins.
Form: tablets, film-coated
Active substance Dosage apixaban 5 mg Manufacturer: Bristol-Myers Squibb/Pfizer Eeig
-
It is used in adults to prevent the formation of blood clots in the heart in people with an irregular heartbeat (atrial fibrillation) and to treat or prevent blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism). It is also used in children from 28 days old up to less than 18 years of age to treat and prevent blood clots in the lungs and veins.
Form: tablets, film-coated
Active substance Dosage apixaban 5 mg Manufacturer: Bristol-Myers Squibb/Pfizer Eeig